Related Experiment Videos
Anticoagulation in atrial fibrillation
Heart & Lung : the Journal of Critical Care
|September 1, 1985
Insights
Patients with atrial fibrillation face significant risks of thromboembolic complications. This review details thromboembolism risks across different atrial fibrillation causes and outlines anticoagulant prophylaxis strategies.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Atrial fibrillation is a common arrhythmia associated with a high risk of stroke and systemic embolism.
- Thromboembolic complications represent a significant source of morbidity and mortality in affected patients.
Observation:
- This vignette examines the varying probabilities of thromboembolism based on the underlying etiology of atrial fibrillation.
- It explores the spectrum of risk factors contributing to clot formation in different patient subgroups.
Findings:
- The review synthesizes data on thromboembolic event rates across diverse causes of atrial fibrillation.
- It highlights key differences in risk profiles necessitating tailored prophylactic approaches.
Implications:
- Understanding etiology-specific risks is crucial for optimizing anticoagulant therapy in atrial fibrillation.
- Effective prophylactic management can significantly reduce the burden of thromboembolic complications.
Abstract:
Thromboembolic complications are a major problem in patients with atrial fibrillation. This vignette presents the probabilities of thromboembolism in the various etiologies of atrial fibrillation and prophylactic management with anticoagulants.